FDA clears Bioness Medical’s neuromodulation system for stroke rehabilitation

Bioness’s PoNS system is designed to improve gait impairment in stroke patients by stimulating the trigeminal and facial cranial nerves. Bioness’s PoNS system is designed to improve gait impairment in stroke patients by stimulating the trigeminal and facial cranial nerves. Neuromodulation is having a significant impact in the healthcare space, with GlobalData analysis projecting that the global neuromodulation device market will reach a valuation of over $13bn in 2035. Credit: daily_creativity/Shutterstock.com Bioness Medical’s oral neuromodulation system for rehabilitating stroke patients with gait deficits has secured clearance from the US Food and Drug Administration (FDA). The California-based company’s portable neuromodulation stimulator…

Source: Medical Device Network